Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBER | UNCY | CRDL | ||
| Company | Ibere Pharmaceuticals Cl A | Unicycive Therapeutics Inc | Cardiol Therapeutics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 10.18 | 7.60 | 1.5300 | ||
| High | 10.18 | 7.60 | 1.6950 | ||
| Low | 10.18 | 7.10 | 1.5150 | ||
| Latest | 10.18 | 7.21 | 1.6300 | ||
| Change | -0.03 | -0.22 | +0.1200 | ||
| % Change | -0.29% | -2.96% | +7.95% | ||
| Volume | 44,400 | 379,800 | 2,401,200 | ||
| 20-Day Average Volume | 61,365 | 573,120 | 1,190,835 | ||
| Previous Close | 10.21 | 7.43 | 1.5100 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.17 | 6.75 | 1.3475 | ||
| 20-Day Raw Stochastic | 5.79% | 74.92% | 91.01% | ||
| 20-Day Relative Strength | 62.60 | 56.00 | 72.99 | ||
| Weighted Alpha | +5.10 | +37.32 | +48.34 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/17/23 | +3.89% since 04/14/26 | +16.43% since 04/14/26 | ||
| Low | 10.17 on 02/21/23 | 6.82 on 04/16/26 | 1.3600 on 04/16/26 | ||
| High | 10.21 on 02/28/23 | 7.60 on 04/21/26 | 1.6950 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +0.20% since 02/01/23 | +7.13% since 03/20/26 | +76.03% since 03/20/26 | ||
| Low | 10.15 on 02/06/23 | 6.05 on 03/30/26 | 0.9100 on 03/23/26 | ||
| High | 10.75 on 02/06/23 | 7.60 on 04/21/26 | 1.6950 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +1.50% since 11/30/22 | +9.24% since 01/21/26 | +59.80% since 01/21/26 | ||
| Low | 10.03 on 12/02/22 | 5.83 on 01/30/26 | 0.8974 on 03/20/26 | ||
| High | 10.75 on 02/06/23 | 7.60 on 04/21/26 | 1.6950 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +3.25% since 09/01/22 | +45.95% since 10/21/25 | +34.71% since 10/21/25 | ||
| Low | 9.87 on 09/02/22 | 4.28 on 11/07/25 | 0.8800 on 12/01/25 | ||
| High | 10.75 on 02/06/23 | 7.60 on 04/21/26 | 1.6950 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 175,605 | 187,518 | 168,844 | ||
| Shares Outstanding, K | 17,250 | 25,238 | 111,817 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 1,560,000 | -26,560,000 | -24,200,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | 789,819 | -14,670,000 | -2,640,000 | ||
| 60-Month Beta | 0.00 | 1.81 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 11/14/22 | -0.82 on 03/30/26 | -0.05 on 03/31/26 | ||
| Latest Earnings Date | 03/06/23 | 05/13/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||